A novel syndrome of paediatric cataract, dysmorphism, ectodermal features, and developmental delay in Australian Aboriginal family maps to 1p35.3-p36.32 by Hattersley, Kathryn et al.
RESEARCH ARTICLE Open Access
A novel syndrome of paediatric cataract,
dysmorphism, ectodermal features, and
developmental delay in Australian Aboriginal
family maps to 1p35.3-p36.32
Kathryn Hattersley
1, Kate J Laurie
1, Jan E Liebelt
2, Jozef Gecz
2,3, Shane R Durkin
1, Jamie E Craig
1,
Kathryn P Burdon
1*
Abstract
Background: A novel phenotype consisting of cataract, mental retardation, erythematous skin rash and facial
dysmorphism was recently described in an extended pedigree of Australian Aboriginal descent. Large scale
chromosomal re-arrangements had previously been ruled out. We have conducted a genome-wide scan to map
the linkage region in this family.
Methods: Genome-wide linkage analysis using Single Nucleotide Polymorphism (SNP) markers on the Affymetrix
10K SNP array was conducted and analysed using MERLIN. Three positional candidate genes (ZBTB17, EPHA2 and
EPHB2) were sequenced to screen for segregating mutations.
Results: Under a fully penetrant, dominant model, the locus for this unique phenotype was mapped to
chromosome 1p35.3-p36.32 with a maximum LOD score of 2.41. The critical region spans 48.7 cM between
markers rs966321 and rs1441834 and encompasses 527 transcripts from 364 annotated genes. No coding
mutations were identified in three positional candidate genes EPHA2, EPHB2 or ZBTB17. The region overlaps with a
previously reported region for Volkmann cataract and the phenotype has similarity to that reported for 1p36
monosomy.
Conclusions: The gene for this syndrome is located in a 25.6 Mb region on 1p35.3-p36.32. The known cataract
gene in this region (EPHA2) does not harbour mutations in this family, suggesting that at least one additional gene
for cataract is present in this region.
Background
The identification of genes for syndromic disorders not
only provides insights into the cause and molecular
pathology of disease but also advances our understand-
ing of their normal function. Although technology has
advanced to the point where large-scale genome-wide
association studies for complex diseases are now feasi-
ble, family based disease gene discovery still plays an
important role, particularly in identifying the genetic
causes of Mendelian disease [1]. Even in the case of rare
syndromes, patients and families benefit from a clear
molecular diagnosis which may assist with prognosis
and clinical management as well as risk prediction
enabling prenatal and preimplantation genetic diagnosis
[2]. In addition, novel disease gene discovery can lead to
insights into the function of those genes and a better
understanding of the underlying biology [3,4]. Many
syndromes have been described where the causative
gene mutation has yet to be identified.
We recently described a novel phenotype in a large
family of Australian Aboriginal descent [5]. The phenotype
is characterised by developmental delay, short stature,
childhood onset cortical cataract, facial dysmorphism, clin-
odactyly, thin hair and an erythematous skin rash. The
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level of second cousins. The two mothers of the 5 affected
male children displayed only a mild cortical cataract not
yet requiring surgery and are of short stature, but do not
display the other features. The cataract in affected males
was severe requiring surgery during early childhood. Initial
inspection of the pedigree suggested X-linked inheritance.
Linkage analysis of the X chromosome failed to detect any
region of the chromosome identical-by-descent in the 5
children, excluding linkage from this chromosome [5] and
therefore suggesting autosomal dominant inheritance.
Thus we have conducted a genome-wide linkage analysis
to localise the gene for this distinctive phenotype.
Methods
This project was approved by the Flinders Clinical
Research Ethics Committee and the Research Ethics
Committee of the Women’s and Children’sH o s p i t a l ,
Adelaide, South Australia. All participants and/or their
guardian gave informed consent. As described previously
[5], DNA was extracted from peripheral whole blood of
all available family members. Simulations for maximum
LOD score were conducted in SLINK [6]. All clearly
diagnosed cases and their parents and siblings (when
available) were genotyped on the Affymetrix 10K SNP
array at the Australian Genome Research Facility using
standard protocols. This array contains ~10,000 Single
Nucleotide Polymorphisms (SNPs). Due to uncertain
affection status in individuals III:5, III:6 and IV:6, they
were not included in the initial genome-wide scan. Link-
age analysis was conducted using the MERLIN program
[7]. Any errors in the genotyping were detected using
the error checking mode of MERLIN and removed
using PEDWIPE before a multipoint linkage analysis
was carried out. A fully penetrant autosomal dominant
model was used with a rare disease frequency of 0.0001.
Haplotypes were also reconstructed in MERLIN.
Six polymorphic SNPs that defined the haplotypes in
the linked region were selected (rs580309, rs718206,
rs720035, rs1416464, rs216036 and rs372151) and geno-
typed using SNaPshot® in all available family members
to determine the carrier status of the linked region in
untyped individuals. Previously typed individuals were
also re-genotyped to ensure correlation between the two
genotyping methods. Briefly, a primer directly adjacent
to the polymorphic nucleotide was annealed to the PCR
product, and a single fluorescently tagged ddNTP was
incorporated according to the manufacturer’sp r o t o c o l s
(Applied Biosystems). The products were then electro-
phoresed on the ABI PRISM 3100 Genetic Analyzer to
detect the alleles.
To identify genes from the linkage interval which are
likely to be expressed in the eye, we searched the NEI-
bank [8] database. Genes were classified as either not
expressed in eye or expressed in one of three categories;
“eye” (includes libraries from whole eye, retina, cornea
etc), “fetal eye” and “lens”. The categories were not
exclusive. All genes expressed in “lens” are also in “eye”.
Candidate genes were chosen from the linked region
on the basis of putative function, expression pattern or
association with congenital cataract. Primers were
designed to amplify the coding exons (including splice
sites) of each gene, and PCR products were directly
sequenced on the ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems, Foster City, CA) with BigDye Ter-
minators (Applied Biosystems) according to standard
protocols. Each exon was sequenced in two affected
individuals, and sequences were compared to the refer-
ence sequence.
Results
Eight family members including 5 boys with a clear diag-
nosis were available for the initial genome-wide analysis
(Figure 1). Affected status was determined as bilateral
cataract as a minimal requirement, but all 5 affected boys
also displayed dysmorphism, erythematous rash and
developmental delay as described previously [5]. Unexa-
mined individuals III:5, III:6 and IV:6 were not included
in the analysis as they were not available for detailed clin-
ical evaluation, making a definitive diagnosis in these
individuals difficult. Individual III:5 was reported to have
had a unilateral cataract removed duing early adulthood,
but no further information was available. Similarly, some
developmental delay was reported in her son IV:6, but
this was unable to be verified, and he was not available to
have a formal cataract examination.
Simulation studies indicated that this family would
generate a maximum LOD score of ~2.4 using the sam-
ples available. Multipoint genome-wide linkage analysis
identified linkage to the telomere of chromosome 1 with
a maximum multipoint LOD score of 2.41 (Figure 2)
using the family members with a clear diagnosis and for
whom sufficient DNA was available. No other regions of
suggestive linkage were detected. Haplotype estimation
identified recombination events in individuals III:2 and
IV:8 which define the critical region to a 48.7 cM region
between rs966321 and rs1441834 on 1p35.3-p36.32 (Fig-
ure 1). The defining markers are ~50 kb and ~820 kb
respectively from the next typed marker, thus suggesting
that additional fine mapping, particularly at the proxi-
mal end could be of value. However, at the distal end
there is only one annotated gene (AJAP1) between
rs966321 and the next linked marker SNP rs1599169.
Similarly, at the proximal end there are no annotated
genes between linked marker rs446335 and defining
marker SNP rs1441834. Thus, additional fine mapping
could only hope to exclude this one gene from the criti-
cal region and thus was not considered a high priority.
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also carry the disease linked chromosome, a selection of
six polymorphic markers from across the linkage region
were typed in the whole family. The haplotypes for the
six markers were constructed (Figure 3), and show that
while III:5 and III:6 are carriers of this disease chromo-
some, IV:6 is not, having inherited the grandpaternal
chromosome from his mother.
The 25.6 Mb linked region contains 531 transcripts
from 364 RefSeq annotated genes extracted from the
USCS Genome Browser, HG19. As cataract has been
used as a characteristic feature on which to base the
designation of “affected”, the expression pattern of each
gene in lens and fetal eye was investigated in silico
through the resources of NEIbank. Of these genes, 136
are not reported to be expressed in eye tissue. Another
140 were found in eye tissues in general, 166 were
reported in fetal eye libraries and 85 in the lens.
While selection of candidate genes from such a long
list of positional candidates is difficult, we noted that
one candidate gene in particular, ZBTB17 is expressed
in skin as well as lens. Given the rash observed as part
of this syndrome this gene became an attractive candi-
date. ZBTB17 (zinc-finger and BTB domain containing
protein 17, myc-interacting protein 1) is a transcription
factor that associates with the microtubules of the cytos-
keleton [9], and interacts with the proto-oncogene myc
[10]. ZBTB17 activates gene transcription in response to
changes in the cytoskeleton and in response to cell-cell
adhesion formation [9,11]. Correct cell adhesion and
morphology is vital to maintaining the transparency of
the ocular lens. ZBTB17 and myc interact to control the
transcription of many genes [10]. They are important in
maintaining homeostasis of skin cells and keratinocytes,
inducing skin stem cells to exit from the cell cycle and
differentiate [12]. All coding regions of the ZBTB17
gene were sequenced in two affected family members
but no mutations were identified.
Recently, we and others reported that mutations in the
EPHA2 gene cause both congenital [13,14] and age-
related cataract [15]. The tendency of EPHA2 to be
associated with the cortical subtype of cataract in adults
was of particular interest as the affected members of
this family displayed the unusual phenotype of juvenile
onset progressive cortical cataract. EPHA2 is a receptor
for ephrin-A5 (EFNA5). Mice deficient in EFNA5 also
develop cataract [16]. The eph-ephrin signalling path-
ways are involved in numerous cellular processes includ-
ing cell morphogenesis, tissue patterning, cell migration,
cell adhesion, cell proliferation and cell-fate determina-
tion. There are a variety of different EPH receptors and
ephrin ligands. Also found within the linked region in
this family is the EPHB2 gene, which along with the
known cataract gene EPHA2 is a receptor for EFNA5.
Thus, we directly sequenced all exons and intron-exon
boundaries of both EPHA2 and EPHB2 in this family.
No mutations were identified in either gene, indicating
that coding mutations are not responsible for the phe-
notype in this family.
Discussion
This study has identified a region on chromosome 1p36
linked to a distinctive phenotype consisting of cortical
cataract, developmental delay, short stature, facial
Figure 1 Pedigree drawing showing haplotypes on chromosome 1p for genotyped family members. The segregating haplotype is
coloured black. All other haplotypes are white. Examined unaffected individuals are marked “N”. Grey symbols indicate “unexamined but
reportedly affected” individuals. The proband IV:5 is marked by an arrow. A “+” symbol indicates those included in the genome-wide scan.
Recombinant individuals III:2 and IV:8 define the critical region between markers rs966321 and rs1441834.
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tous skin rash. Many other syndromes and diseases have
also been shown to link to this region, some of which
show significant phenotypic overlap with this family.
Notably, terminal or interstitial deletions of 1p36 show a
spectrum of features with marked similarity [17]. Nearly
100% of such patients display mental retardation and
developmental delay. Characteristic dysmorphic features
observed in the majority of this group of patients
include large anterior fontanelle, microcephaly, brachy-
cephaly, dysmorphic ears, flat nasal bridge, pointed chin
and clinodactyly. Conductive hearing loss is also
reported and is present in the family reported here. It is
highly probable that many of these overlapping features
Figure 2 Linkage analysis. A) Multipoint genome-wide LOD scores. Linkage was calculated in MERLIN using family members marked with “+”
on Figure 1, under a fully penetrant dominant model. Horizontal line marks LOD = 3.0. Arrow indicates linkage peak on chromosome 1p. B)
Multipoint LOD scores on chromosome 1. The peak extends from SNP rs966321 to rs1441834 (8.0-56.7 cM), Max LOD = 2.41.
Figure 3 Phased haplotypes for all genotyped members of the family. Affected individuals and the segregating haplotype are shaded grey.
Participants of uncertain diagnosis and carrier status are marked in bold. Both III:5 and III:6 clearly carry the segregating disease haplotype while
IV:6 likely does not. Unaffected individuals IV:1, IV:3 and IV:9 do not carry this haplotype. “?” indicates allele not scored.
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ble for the phenotype in this family. Cataract is not
commonly reported in 1p36 deletion patients, although
other eye anomalies such as hypermetropia, myopia and
strabismus are relatively common. This may be due to
the effect of monosomy compared with a mutation that
disrupts normal protein function.
It is highly unlikely that this family carries a contigu-
ous gene deletion on 1p36 by virtue of the heterozygos-
ity observed throughout the linked region in all affected
individuals, although microdeletions in between markers
cannot be ruled out. Array based comparative genomic
hybridisation (aCGH) previously failed to identify any
copy number variants with a resolution of 0.2-1.0 Mb
[5]. Ten of the 63 linked markers show homozygosity in
all affected individuals but only two of these markers
are contiguous (rs2319403 and rs2319404). These two
SNPs are located only 131 bp apart in an intron of the
PTPRU gene. This gene is a plausible candidate as it is
reported to be expressed in the crystalline lens and
is involved in cell-cell adhesions, interacting with
beta-catenin and E cadherin [18]. The next flanking
heterozygous markers define a region of nearly 380 kb
containing five genes (EPB41, TMEM200B, SFRS4, MECR
and PTPRU) all of which are expressed in lens. A microde-
letion in this region encompassing the two homozygous
markers and thus disrupting at least the PTPRU gene
cannot be completely ruled out with this methodology.
Other known syndromes mapping to 1p36 with pheno-
typic overlap with this family include Zellweger syn-
drome, galactose epimerase deficiency, and congenital
and age-related cataract. Zellweger Syndrome (OMIM
#214100) is a fatal recessive disease affecting the brain,
liver and kidneys [19]. It is caused by disruption to per-
oxisome biogenesis. Many genes are known to cause the
disease, including PEX14 on 1p36 [20]. This gene is
known to be expressed in the eye and some reports of
Zellwegger syndrome describe ocular features. Notably,
parents of affected babies (i.e. heterozygous carriers of
the condition) have been shown to have mild cataract,
described as “curvilinear cortical condensations” [19],
although comparison of the photographs published by
Hittner et al [19] do not resemble the cataract observed
in this family [5]. Galactose epimerase deficiency (OMIM
#230350) is another syndrome mapping to 1p36 that can
lead to cataracts. Deficiency of the UDP-galactose-4-epi-
merase (GALE) gene results in a form of galactosemia,
with an inability to metabolise galactose and increases
the risk of cataracts. Some patients also display develop-
mental delay. Both age-related cortical cataract (OMIM
#613020) and congenital posterior polar or total cataract
(OMIM #116600) have been linked to 1p36 with the
EPHA2 gene recently being described as causative of
both conditions [13-15]. Coding mutations of EPHA2
have been ruled out in the family in the current report,
but intronic or distant regulatory mutations remain a
possibility. A second locus for congenital cataract (Volk-
mann type, OMIM #115665) has also been reported on
1p36 [21]. The linkage region does not encompass the
EPHA2 gene, however it does overlap with the region
described in this Australian family (Figure 4). Although
the Volkmann cataract phenotype is not syndromic and
is likely distinct from that described in this family, it is
possible that the two are allelic.
The number of potential candidate genes for this phe-
notype in the linked region is very large. While expres-
sion information is useful in prioritising genes for
analysis, the number of genes to assess in this particular
case remains large, and expression profiles generated by
EST libraries and micorarray information are not exhaus-
tive, meaning even more genes are potential candidates.
It was initially thought that this pedigree displayed
X-linked inheritance, due to a milder phenotype observed
in females III:2 and III:9. However, a thorough evaluation
of the X chromosome ruled out this possibility [5], which
was confirmed by re-analysis of the X chromosome in
this genome-wide study. The reason for the differential
expression in the females of generation III and the males
of generation IV is not clear. Anticipation may be an
explanation for generational differences. It is also possible
that the gene responsible is regulated differently in males
and females or that the gene product interacts with other
factors (eg sex hormones) pre s e n ta td i f f e r e n tl e v e l si n
males and females. Alternatively, the genetic background
Figure 4 Schematic of the linkage region. Overlap of the linkage region in this family with the mapped Volkmann Cataract region is shown
along with the location of other genes causing cataract phenotypes (PEX14, EPHA2 and GALE)
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III:2 and III:9 carrying a common inherited protective
allele at an independent interacting locus not passed on
to the affected offspring.
Conclusion
We have localised the region for a novel phenotype
characterised by cataract, mental retardation, erythema-
tous rash and facial dysmorphism to a region on chro-
mosome 1p36. Further evaluation of all linked genes is
required to identify the causative gene.
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